Ftse Mib
34.249,77
0,91%
DAX
18.161,01
1,32%
S&P 500
5.099,96
1,02%
NASDAQ Composite
15.927,90
2,03%
Bitcoin
62.846,36
-1,40%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Assistenza
Home Investire Azioni U.S.A. NASDAQ Aadi Bioscience Inc (AADI) Aadi Bioscience Inc (AADI) Notizie

Aadi Bioscience Inc

AADI
1,7494
0,0694 (4,13%)
27 Apr 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
09/4/202414:00PRNUSAadi Bioscience to Present New Non-clinical Data..
17/3/202413:00PRNUSAadi Bioscience Presents New Subgroup Analysis of Patients..
13/3/202413:00PRNUSAadi Bioscience Announces Financial Results for the Fourth..
06/3/202414:00PRNUSAadi Bioscience to Report Fourth Quarter and Full-Year 2023..
05/3/202422:30PRNUSAadi Bioscience to Present Multiple Posters at the American..
05/3/202401:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202401:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202401:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202422:08PRNUSAadi Bioscience Announces Publication of Long-Term Efficacy..
01/3/202419:07EDGAR2Form 144 - Report of proposed sale of securities
26/2/202422:05PRNUSAadi Bioscience to Present at the TD Cowen 44th Annual..
12/2/202423:21EDGAR2Form S-8 - Securities to be offered to employees in employee..
12/2/202423:16EDGAR2Form S-3 - Registration statement under Securities Act of..
02/2/202423:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202422:05PRNUSAadi Bioscience Announces Poster Presentations at the 2024..
19/1/202422:05PRNUSAadi Bioscience Announces Poster Presentations at the 2024..
03/1/202401:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202323:08EDGAR2Form 8-K - Current report
14/12/202322:05PRNUSAadi Bioscience Reports Interim Results from PRECISION1..
07/12/202322:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202300:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202317:37EDGAR2Form 144 - Report of proposed sale of securities
08/11/202322:54EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202322:28EDGAR2Form 8-K/A - Current report: [Amend]
08/11/202314:07EDGAR2Form 8-K - Current report
08/11/202314:00PRNUSAadi Bioscience Reports Financial Results for the Third..
06/11/202322:05PRNUSAadi Bioscience to Participate in Jefferies London..
02/11/202323:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202321:05PRNUSAadi Bioscience to Report Third Quarter 2023 Results and..
19/10/202322:05PRNUSAadi Bioscience Announces Poster Presentations on..
12/10/202322:05PRNUSAadi Bioscience Announces Poster Presentations at 2023..
05/10/202322:05PRNUSAadi Bioscience Announces Poster Presentations at the North..
04/10/202300:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202300:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202300:47EDGAR2Form 3 - Initial statement of beneficial ownership of..
03/10/202322:05PRNUSAadi Bioscience Grants New CEO Dave Lennon, Ph.D. Inducement..
02/10/202314:30EDGAR2Form 8-K - Current report
02/10/202314:00PRNUSAadi Bioscience Appoints Dave Lennon, Ph.D. as President and..
20/9/202322:30PRNUSAadi Bioscience Announces Poster Presentations at 2023..
07/9/202301:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202314:00PRNUSAadi Bioscience to Participate at Upcoming Investor..
01/9/202317:33EDGAR2Form 144 - Report of proposed sale of securities
09/8/202322:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202314:05EDGAR2Form 8-K - Current report
09/8/202314:00PRNUSAadi Bioscience Announces Financial Results for the Second..
03/8/202322:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/8/202314:00PRNUSAadi Bioscience to Report Second Quarter 2023 Results and..
07/7/202301:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/7/202317:48EDGAR2Form 144 - Report of proposed sale of securities
25/5/202323:30PRNUSAadi Bioscience Announces Presentations at the 2023 American..
Apertura: 1,67 Min: 1,66 Max: 1,76
Chiusura: 1,68

La tua Cronologia

NASDAQ
AADI
Aadi Bioscience
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network